# Impact of Total Intravenous Anesthesia Following Cancer Surgery, TIVACS Study

> **NCT04992507** · PHASE2 · TERMINATED · sponsor: **Ohio State University Comprehensive Cancer Center** · enrollment: 8 (actual)

## Conditions studied

- Pancreatic Adenocarcinoma

## Interventions

- **PROCEDURE:** Anesthesia Procedure
- **DRUG:** General Anesthesia Procedure
- **PROCEDURE:** Resection

## Key facts

- **NCT ID:** NCT04992507
- **Lead sponsor:** Ohio State University Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-06-02
- **Primary completion:** 2024-01-26
- **Final completion:** 2024-01-26
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Principal investigator departed sponsoring organization
- **Last updated:** 2025-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04992507

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04992507, "Impact of Total Intravenous Anesthesia Following Cancer Surgery, TIVACS Study". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04992507. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*